Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.
about
Ephs and ephrins in cancer: ephrin-A1 signallingMicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteinsDifferential gene expression profiles in stage I primary biliary cirrhosis.GALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma.Eph receptors and ephrins in cancer: bidirectional signalling and beyond.Identification of target actin content and polymerization status as a mechanism of tumor resistance after cytolytic T lymphocyte pressure.Serum tumor markers for detection of hepatocellular carcinoma.A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1.Risk factors for residual tumor after resection of hepatocellular carcinoma.Expression of EPHRIN-A1, SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD8+ T cells.Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell.Eph receptors and ephrins as targets for cancer therapy.The effect of ephrin-A1 on resistance to Photofrin-mediated photodynamic therapy in esophageal squamous cell carcinoma cells.Biomimetic hydrogels with immobilized ephrinA1 for therapeutic angiogenesisEphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway.Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges.Translational microarray systems for outcome prediction of hepatocellular carcinoma.Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B.MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cellsCyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma.Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma.Ephrin expression and function in cancer.Screening of liver-targeted drugs.The alpha-fetoprotein (AFP) third domain: a search for AFP interaction sites of cell cycle proteins.Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy.Alpha-1-antitrypsin deficiency resulting in a hitherto unseen presentation of hepatocellular carcinoma: polycythemia but with normal alpha fetoprotein.Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway.The proangiogenic factor ephrin-A1 is up-regulated in radioresistant murine tumor by irradiation.Increased EphB2 expression predicts cholangiocarcinoma metastasis.
P2860
Q26864889-C19FB9ED-1CBC-48C4-B337-F9933A95D957Q29615034-6A29C46D-8E7E-404C-A90C-EF05E6C38317Q33222514-AA39FF94-3A6A-4528-A817-9078195A27F3Q33733830-57746A9A-41F6-4B96-B5BF-2DC17814F06FQ34021365-7E13E244-708C-484D-A86F-B904D6A5DCA4Q34335039-548FBBFF-0A24-468C-8902-75A932E6D770Q34501851-B6B5DEE3-F48C-48CB-834A-847B17A95380Q34512240-BFC457F2-99F6-41DF-B485-531C80D297D6Q34831310-F7DA1464-ABFD-403F-987B-8E99A79CD009Q35065243-09ECE3A7-67F9-438C-BE00-ED424E31F759Q35109163-259F1071-E8AC-4B06-8C06-73CF93AE3E9FQ35370195-4A62BDE2-AE95-4AEE-80FA-B5691846698CQ35801194-CD228883-6235-4AAD-ADC1-286B35945E49Q35896879-4AC31847-6258-4A14-849F-1E0CF1D9FD3AQ36785760-02D9DA87-F159-4736-963B-83CB60E4B74BQ36802501-75D3031D-D0B0-4C64-A7FF-DE511C7E971DQ37123504-9689B513-E01C-4F10-89CB-E1D93960CF45Q37212974-DC4E9B02-E4B6-4A22-8755-1CAC265E41A9Q37298299-FCB595E6-4E88-4861-94D9-723B2BF024EDQ37317180-F60C687B-CB29-4219-8198-C37C48C8EA33Q37457607-0E77555D-C8E3-4DF2-8CFB-2E9303A555EDQ37658786-A98595E9-2C9A-4201-915D-B147D5DC23BEQ38090671-14CA7D7B-1A37-40E9-BA9E-45E911990A21Q39570078-95E98B84-281A-4CD3-ABDB-CDCD79B6AFA4Q41107415-9335B071-0108-471B-80A7-53B3642E88BFQ41412266-ADC509AE-6566-4073-BD7F-FA760FC5E389Q42111318-8E7E1914-68A2-42FC-9E98-36B73FCE6204Q43240643-C8BAF921-CF46-4C49-8920-0BE91053AABDQ46255952-9C28F49F-5A23-40B8-ACD9-053D81415793Q54338851-716DE9D2-0D4C-4EFB-9C61-391378D07A28
P2860
Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Ephrin-A1 expression contribut ...... cing hepatocellular carcinoma.
@en
type
label
Ephrin-A1 expression contribut ...... cing hepatocellular carcinoma.
@en
prefLabel
Ephrin-A1 expression contribut ...... cing hepatocellular carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Ephrin-A1 expression contribut ...... cing hepatocellular carcinoma.
@en
P2093
T Yamashita
P2860
P304
P356
10.1136/GUT.2004.049486
P407
P577
2005-06-01T00:00:00Z